Status:
RECRUITING
Natural History of Treated Neurocysticercosis and Long-Term Outcomes
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Cysticercosis
Neurocysticercosis
Eligibility:
All Genders
3-99 years
Brief Summary
Neurocysticercosis is a brain disease due to the larval stage of the pork tapeworm (Taenia solium). The most common symptoms patient experience from infection inside the substance of the brain (parenc...
Detailed Description
Study Description: The purpose of this protocol is to follow participants with cysticercosis during and after completion of treatment, to characterize the disease course during both short- and long-t...
Eligibility Criteria
- INCLUSION CRITERIA:
Arms 1-5 (NCC):
- Aged 3 years and older.
- Ability of participant (or legally authorized representative, LAR) to understand and the willingness to sign a written informed consent document.
- Patients with proven or likely NCC
Arm 6 (Endemic Exposures):
- Patient with epidemiologic history compatible with possible exposure to NCC
- Aged 18 years and older.
EXCLUSION CRITERIA:
Not applicable
Key Trial Info
Start Date :
October 7 1985
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT00001205
Start Date
October 7 1985
Last Update
April 29 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892